Sygnus Biotech Logo
AZINUS-200
Rx Only
Ready for 24-48h Central Dispatch
In Stock

AZINUS-200 Clinical Monograph & Batch COA

Certified DCGI Formulation Literature (PDF)

Download
SyrupPrescription Required (Schedule Drug)

AZINUS-200

5.0(1 review)
Verified Quality Batch
Active Drug Composition

Azithromycin 200mg Oral Suspension

WHO-GMP Certified Batch ManufacturingDCGI Approved Formulation100% BioavailableAlu-Alu Packaging

AZINUS-200 is a broad-spectrum bactericidal antimicrobial agent exhibiting enhanced pharmacokinetic tissue penetration against susceptible gram-positive and gram-negative pathogens.

Dosage FormOral Suspension
Packaging Presentation30ml
B2B Distributor & Healthcare Professional Notice:This product is supplied solely through verified licensed pharmaceutical distributors, stockists, and institutional tenders. Online retail checkout for prescription formulations is legally restricted.

Clinical Pharmacology & Therapeutic Profile

Comprehensive therapeutic guidelines for medical practitioners and institutional procurement

Therapeutic Indications

Lower Respiratory Tract Infections
Acute Bacterial Sinusitis
Urinary Tract Infections (UTI)
Skin and Soft Tissue Infections
Community-Acquired Pneumonia

Mechanism of Action (MOA)

Inhibits bacterial DNA gyrase (type II topoisomerase) and topoisomerase IV enzymes required for bacterial DNA replication, transcription, and repair.

Dosage & Posology

Adult: One dose once or twice daily depending on infectious severity. Complete full course to prevent antimicrobial resistance.

Safety & Precautions

Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.

Storage Guidelines

Store below 25°C. Do not freeze. Keep container tightly closed.

WHO-GMP Certified Purity

Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.

Alu-Alu Moisture Barrier

Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.

Exclusive District Monopoly

Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.

Technical Product Specifications

Therapeutic SegmentSyrup
Dosage FormOral Suspension
Packaging Type30ml
Regulatory ScheduleSchedule H
Country of OriginIndia
Quality StandardWHO-GMP & ISO 9001:2015
Batch Analytical COASupplied with Trade Invoice

Active Medical Composition

AZINUS-200 features Azithromycin 200mg Oral Suspension prepared to high pharmaceutical purity standards.

Therapeutic ClassificationSyrup
Regulatory ScheduleSchedule Drug (Prescription Only)

*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.

Verified Practitioner & Distributor Feedback

Customer & Clinical Reviews

Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.

5.0

Based on 1 verified review

5
1 (100%)
4
0 (0%)
3
0 (0%)
2
0 (0%)
1
0 (0%)
Verified Feedback
30 May 2026

Evaluated across our institutional for AZINUS-200

AZINUS-200 has been evaluated across our institutional healthcare network, leading to verified clinical improvement without secondary complaints or nausea. The pack design is aesthetically modern with distinct therapeutic labeling that eliminates dispensing errors. Both consulting doctors and stocking pharmacists rate this formulation among the best in its class.

Maheshwari Medical Stores•Authorized Stockist & Chemist, Indore
Distributor Inquiries

Questions Regarding AZINUS-200

What is the therapeutic indication and composition of AZINUS-200?

AZINUS-200 contains Azithromycin 200mg Oral Suspension indicated for Lower Respiratory Tract Infections as formulated by Sygnus Biotech.

What packaging presentations are available for AZINUS-200?

AZINUS-200 is supplied in tamper-evident 100ml / 200ml PET Bottle with Graduated Measuring Cap, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.

Is monopoly PCD franchise territory available for AZINUS-200?

Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for AZINUS-200 along with promotional visual aids, product cards, and marketing support.

What is the regulatory schedule and minimum order quantity (MOQ)?

AZINUS-200 is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.

Related Formulations in Syrup

View all Syrup →
Syrup
S-KRAL

S-KRAL

Oxetacaine 20mg + Sucralfate 1gm

Pack:100ml
Syrup
SB CAIN GEL

SB CAIN GEL

Oxetacaine 10mg + Aluminium Hydroxide 0.291gm

Pack:200ml
Syrup
TRYLAX

TRYLAX

Liquid Paraffin 1.25ml + Milk of Magnesia 3.75ml + Sodium Picosulphate 3.33mg

Pack:170ml
Syrup
SYPROVIT

SYPROVIT

Cyproheptadine HCl 2mg + Tricholine Citrate 0.275mg

Pack:200ml
Monopoly PCD Franchise

Apply for Exclusive Marketing Rights of AZINUS-200

Check vacant territory availability in your state or district. Enjoy full marketing kit support, visual aids, and guaranteed zero competitor supply.